Replicate study designs are essential for assessing bioequivalence of highly variable drugs. They reduce sample sizes, improve accuracy, and meet global regulatory standards like FDA and EMA guidelines for RSABE.
4
Dec
Replicate study designs are essential for assessing bioequivalence of highly variable drugs. They reduce sample sizes, improve accuracy, and meet global regulatory standards like FDA and EMA guidelines for RSABE.
